US Pharma MarketingNovo sues Lilly after alleged misleading and false advertising campaign
In a lawsuit filed in the US, Novo alleged that Lilly’s campaign was designed to mislead consumers on “comparative efficacy” of drug brands.
In a lawsuit filed in the US, Novo alleged that Lilly’s campaign was designed to mislead consumers on “comparative efficacy” of drug brands.
Source: Pharmaceutical Technology